PKM and non-small cell lung carcinoma: In contrast, treatment of NSCLC lines with SMI for 48 hours or sh-RNA-PKM2 resulted in a decrease in cytoplasmic enzyme activity with a concomitant rise in nuclear PKM2 enzyme activity (Fig 4A).